The trial is the first to compare Xeljanz alone or in combination with MTX versus adalimumab plus MTX.
Specialty Pharmacy
Advertisement
Boehringer Ingelheim seeks to launch its biosimilar to Humira.
Advertisement
Reports confirm 10 hepatitis A-related deaths in Detroit area over the past year.
Two KEYNOTE trials were placed on full clinical hold and 1 partial clinical hold.
Abatacept (Orencia) receives approval for third autoimmune condition.
Top news of the day from across the health care landscape.
Advertisement
Research may lead to the development of safer therapies for pregnant women with rheumatoid arthritis.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
The approval greatly expands treatment options for rare inherited blood disorder.
Scientists highlight the potential use of exosomes to detect and treat diseases.
Advertisement
Changing from a biologic to a biosimilar can create insecurity among patients with RA.
Top articles of the week from Specialty Pharmacy Times.
Elevated protein levels may indicate a need for both chemotherapy and surgery for colon cancer.
Anti-fungal therapy may prove beneficial in patients with Crohn’s disease.
Top news of the day from across the health care landscape.
Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses how to increase the utilization of biosimilars across the industry.
Researchers focus on generating a robust HIV-neutralizing antibody response.
Grape compounds may be an effective treatment option for colon cancer patients.
A specific immune T cell protects patients with lung cancer.
Clinical trial shows efficacy of Janus kinase inhibitor and methotrexate.
Mathematical model brings scientists a step closer to developing total viral suppression strategies among patients with HIV.
Sandoz has the highest number of biosimilars approved in Europe.
Some hair care products may cause increased cancer risk.
Top news of the day from across the health care landscape.
Waiting to get treatment for breast cancer results is worse survival outcomes.
Rheumatoid arthritis should be included to list of medical conditions linked to obesity.
Radioactive particles attack skin and increase the risk of skin cancer.
Patients with rheumatic and musculoskeletal disease can maintain a sustainable work life through educational programs.
Study will examine the safety and efficacy of tralokinumab monotherapy in treating atopic dermatitis.
Top news of the day from across the health care landscape.
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
3
Beyond Weight Loss: Exploring the Renal and Anti-Inflammatory Benefits of High-Dose Semaglutide
4
Adults With Schizophrenia Remain Stable When Transitioning from Atypical Antipsychotic to Cobenfy
5